Skip to main content
Top
Published in: Pediatric Nephrology 4/2004

01-04-2004 | Brief Report

Nephrogenic fibrosing dermopathy in pediatric patients

Authors: Sima M. Jain, Stanton Wesson, Ashraf Hassanein, Erica Canova, Miranda Hoy, Robert S. Fennell, Vikas R. Dharnidharka

Published in: Pediatric Nephrology | Issue 4/2004

Login to get access

Abstract

Nephrogenic fibrosing dermopathy (NFD) is a rare and recently recognized sclerosing skin disorder of unknown etiology. Reported cases have occurred in patients with chronic renal failure, with or without renal replacement therapy. All previous cases have been reported in older adult patients. We describe two pediatric patients who recently developed this condition and review the existing literature for NFD. Our patients included an 8-year-old boy on peritoneal dialysis with no prior renal transplant and a 19-year-old boy on hemodialysis with a history of previous failed renal transplants. We speculate that the recent emergence of this condition and occurrence in patients with chronic renal failure suggest an association with some newer pharmacological agent that has recently come into wide use. Since both our patients also had previously experienced large vessel thrombosis, hypercoagulable states may also be implicated.
Literature
1.
go back to reference Cowper SE, Robin HS, Steinberg SM, Su LD, Gupta S, LeBoit PE (2000) Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 356:1000–1001CrossRefPubMed Cowper SE, Robin HS, Steinberg SM, Su LD, Gupta S, LeBoit PE (2000) Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 356:1000–1001CrossRefPubMed
2.
go back to reference Mackay-Wiggan JM, Cohen DJ, Hardy MA, Knobler EH, Grossman ME (2003) Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease). J Am Acad Dermatol 48:55–60CrossRefPubMed Mackay-Wiggan JM, Cohen DJ, Hardy MA, Knobler EH, Grossman ME (2003) Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease). J Am Acad Dermatol 48:55–60CrossRefPubMed
3.
go back to reference Cowper SE, Su LD, Bhawan J, Robin HS, LeBoit PE (2001) Nephrogenic fibrosing dermopathy. Am J Dermatopathol 23:383–393CrossRefPubMed Cowper SE, Su LD, Bhawan J, Robin HS, LeBoit PE (2001) Nephrogenic fibrosing dermopathy. Am J Dermatopathol 23:383–393CrossRefPubMed
4.
go back to reference Perazella MA, Ishibe S, Reilly RF (2003) Nephrogenic fibrosing dermopathy: an unusual skin condition associated with kidney disease. Semin Dial 16:276–280CrossRefPubMed Perazella MA, Ishibe S, Reilly RF (2003) Nephrogenic fibrosing dermopathy: an unusual skin condition associated with kidney disease. Semin Dial 16:276–280CrossRefPubMed
5.
go back to reference Streams BN, Liu V, Liegeois N, Moschella SM (2003) Clinical and pathologic features of nephrogenic fibrosing dermopathy: a report of two cases. J Am Acad Dermatol 48:42–47CrossRefPubMed Streams BN, Liu V, Liegeois N, Moschella SM (2003) Clinical and pathologic features of nephrogenic fibrosing dermopathy: a report of two cases. J Am Acad Dermatol 48:42–47CrossRefPubMed
6.
go back to reference Swartz RD, Crofford LJ, Phan SH, Ike RW, Su LD (2003) Nephrogenic fibrosing dermopathy: a novel cutaneous fibrosing disorder in patients with renal failure. Am J Med 114:563–572CrossRefPubMed Swartz RD, Crofford LJ, Phan SH, Ike RW, Su LD (2003) Nephrogenic fibrosing dermopathy: a novel cutaneous fibrosing disorder in patients with renal failure. Am J Med 114:563–572CrossRefPubMed
7.
go back to reference Cowper S, LeBoit PE, Su LD, Grossman ME, Windham G, Gilliss D, et al (2002) Public health dispatch: fibrosing skin condition among recipients with renal disease—United States and Europe 1997–2002. MMWR 51:25–26 Cowper S, LeBoit PE, Su LD, Grossman ME, Windham G, Gilliss D, et al (2002) Public health dispatch: fibrosing skin condition among recipients with renal disease—United States and Europe 1997–2002. MMWR 51:25–26
8.
go back to reference McNeill AM, Barr RJ (2002) Scleromyxedema-like fibromucinosis in a patient undergoing hemodialysis. Int J Dermatol 41:364–367CrossRefPubMed McNeill AM, Barr RJ (2002) Scleromyxedema-like fibromucinosis in a patient undergoing hemodialysis. Int J Dermatol 41:364–367CrossRefPubMed
9.
go back to reference Hubbard V, Davenport A, Jarmulowicz M, Rustin M (2003) Scleromyxoedema-like changes in four renal dialysis patients. Br J Dermatol 148:563–568PubMed Hubbard V, Davenport A, Jarmulowicz M, Rustin M (2003) Scleromyxoedema-like changes in four renal dialysis patients. Br J Dermatol 148:563–568PubMed
10.
go back to reference Mach JR Jr, Korchik WP, Mahowald MW (1988) Dialysis dementia. Clin Geriatr Med 4:853–867PubMed Mach JR Jr, Korchik WP, Mahowald MW (1988) Dialysis dementia. Clin Geriatr Med 4:853–867PubMed
11.
go back to reference Fine A, Zacharias J (2002) Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy. Kidney Int 61:2210–2217CrossRefPubMed Fine A, Zacharias J (2002) Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy. Kidney Int 61:2210–2217CrossRefPubMed
12.
go back to reference Plone MA, Petersen JS, Rosenbaum DP, Burke SK (2002) Sevelamer, a phosphate-binding polymer, is a non-absorbed compound. Clin Pharmacokinet 41:517–523PubMed Plone MA, Petersen JS, Rosenbaum DP, Burke SK (2002) Sevelamer, a phosphate-binding polymer, is a non-absorbed compound. Clin Pharmacokinet 41:517–523PubMed
13.
go back to reference Marco MP, Muray S, Betriu A, Craver L, Belart M, Fernandez E (2002) Treatment with sevelamer decreases bicarbonate levels in hemodialysis patients. Nephron 92:499–500CrossRefPubMed Marco MP, Muray S, Betriu A, Craver L, Belart M, Fernandez E (2002) Treatment with sevelamer decreases bicarbonate levels in hemodialysis patients. Nephron 92:499–500CrossRefPubMed
14.
go back to reference Sprague SM, Lerma E, McCormmick D, Abraham M, Batlle D (2001) Suppression of parathyroid hormone secretion in hemodialysis patients: comparison of paricalcitol with calcitriol. Am J Kidney Dis 38 [Suppl 5]:S51–S56 Sprague SM, Lerma E, McCormmick D, Abraham M, Batlle D (2001) Suppression of parathyroid hormone secretion in hemodialysis patients: comparison of paricalcitol with calcitriol. Am J Kidney Dis 38 [Suppl 5]:S51–S56
15.
go back to reference Cowper SE, Bucala R (2003) Nephrogenic fibrosing dermopathy: suspect identified, motive unclear. Am J Dermatopathol 25:358CrossRefPubMed Cowper SE, Bucala R (2003) Nephrogenic fibrosing dermopathy: suspect identified, motive unclear. Am J Dermatopathol 25:358CrossRefPubMed
16.
go back to reference Baron PW, Cantos K, Hillebrand DJ, Hu KQ, Ojogho ON, Nehlsen-Cannarella S, Concepcion W (2003) Nephrogenic fibrosing dermopathy after liver transplantation successfully treated with plasmapheresis. Am J Dermatopathol 25:204–209CrossRefPubMed Baron PW, Cantos K, Hillebrand DJ, Hu KQ, Ojogho ON, Nehlsen-Cannarella S, Concepcion W (2003) Nephrogenic fibrosing dermopathy after liver transplantation successfully treated with plasmapheresis. Am J Dermatopathol 25:204–209CrossRefPubMed
Metadata
Title
Nephrogenic fibrosing dermopathy in pediatric patients
Authors
Sima M. Jain
Stanton Wesson
Ashraf Hassanein
Erica Canova
Miranda Hoy
Robert S. Fennell
Vikas R. Dharnidharka
Publication date
01-04-2004
Publisher
Springer-Verlag
Published in
Pediatric Nephrology / Issue 4/2004
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-003-1380-1

Other articles of this Issue 4/2004

Pediatric Nephrology 4/2004 Go to the issue